GVK Biosciences Private Limited (GVK BIO), one of Asia's leading CROs, announced the appointment of Dr Shoibal Mukherjee as senior vice president - Clinical Development.

"Expanding and enriching our leadership team is critical for GVK BIO's vision of being a leading life-sciences services company," said D S Brar, chairman, GVK BIO. "Dr Shoibal Mukherjee has extensive experience in managing global clinical trials and will play a pivotal role in the growth of the company's 'Development' services."

Prior to joining GVK BIO, Dr Mukherjee served in Ranbaxy and Pfizer in senior positions. Dr Mukherjee graduated as a physician and is an MD and DM in Pharmacology. Professionally trained in clinical & pharmaceutical medicine, Dr. Mukherjee has vast experience in managing Clinical Trials, Medical Affairs, Clinical Data Management, and Clinical Pharmacology.

Dr Mukherjee has authored several research papers and is a visiting faculty for established universities and medical institutions. Dr Mukherjee is the founding president of the Indian Society for Clinical Research and a member of several committees.

Dr Mukherjee is the most recent in a series of senior-level appointments at GVK BIO.

Earlier this year, GVK BIO had recruited Dr Sailendra Goswami as vice president for Clinical Pharmacology. Dr Goswami previously worked as CEO of Veeda Clinical Research Pvt Ltd and played a key role right from its inception.

GVK BIO has also strengthened its international Clinical Research Business Development team by recruiting William Harel as vice president - Business Development, in the West Coast of USA. PhD in Immunology, William is responsible for developing the business of Clinical Research in the US and globally. William has over 20 years of experience in various companies including Chiron Corporation, AAI Pharma and Neeman Medical International.

In addition to its well established services in Discovery Research and Informatics, GVK BIO offers Clinical Development services that span Special population studies to phase-II - IV clinical trials, Data Management, Biostatistics, Medical Writing, Pharmacovigilance, Bioequivalence studies, and Bioanalytical services.